115372 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66748)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (661)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5599)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115372)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor epichaperome expression using (124)I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Dunphy, M.; Wang, R.; Comen, E.; Fornier, M.; Moynahan, M. E.; Bromberg, J.; Ma, W.; Patil, S.; Taldone, T.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Whole exome sequencing analysis of the progression from ductal carcinoma in situ to invasive ductal carcinoma
    Meeting Abstract

    Lee, J. Y.; Bi, R.; Pareja, F.; Geyer, F. C.; Brown, D.; Wen, H. Y.; Norton, L.; Hicks, J.; Weigelt, B.; Reis-Filho, J. S.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • The landscape of somatic genetic alterations in breast cancers from CHEK2 germline mutation carriers
    Meeting Abstract

    Kumar, R.; Pei, X.; Selenica, P.; Wen, H. Y.; Powell, S.; Robson, M.; Riaz, N.; Reis-Filho, J. S.; Weigelt, B.; Mandelker, D.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Unraveling lobular breast cancer progression and endocrine resistance mechanisms through genomic and immune characterization of matched primary and metastatic samples
    Meeting Abstract

    Desmedt, C.; Richard, F.; Majjaj, S.; Pingitore, J.; Brown, D.; Rothe, F.; Marchio, C.; Clatot, F.; Mariani, O.; Boeckx, B.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A preliminary assessment of knowledge, attitudes, and awareness surrounding ESR1 mutations and biomarker testing amongst medical oncologists
    Meeting Abstract

    Goldfarb, S. B.; Goetz, M. P.; Plourde, P. P.; Attias, E.; Portman, D. J.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Development and validation of a chemotherapy toxicity (Chemo Tox) risk score for older patients (Pts) with breast cancer (BC) receiving adjuvant/neoadjuvant treatment (Adjuvant Tx): A R01 and BCRF funded prospective multicenter study
    Meeting Abstract

    Hurria, A.; Magnuson, A.; Gross, C. P.; Tew, W. P.; Klepin, H. D.; Wildes, T. M.; Muss, H. B.; Dotan, E.; Freedman, R.; O'Connor, T.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Obesity, adipose inflammation, and race in patients with early stage breast cancer
    Meeting Abstract

    Iyengar, N. M.; Siegel, B.; Malik, M.; Giri, D. D.; Tsai, J.; Hughes, M.; Adam, A.; Williams, S.; Zhou, X. K.; Rodgers, W.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Correlation of CDH1 alterations and aberrant E-cadherin expression in lobular carcinomas
    Meeting Abstract

    Grabenstetter, A.; Mohanty, A. S.; DeLair, D. F.; Tan, L. K.; Ross, D. S.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A p53-independent DNA damage response that regulates breast cancer phenotypes
    Meeting Abstract

    Fagan-Solis, K. D.; Simpson, D. A.; Kapustina, M.; Martelotto, L.; Reis-Filho, J. S.; Petrini, J. H.; Gupta, G. P.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase 1/1b study of novel oral selective estrogen receptor degrader (SERD) LSZ102 in combination with alpelisib (BYL719) in estrogen receptor-positive (ER plus ), human epidermal growth factor receptor-2-negative (HER2-) advanced breast cancer (ABC) with progression on endocrine therapy (ET)
    Meeting Abstract

    Curigliano, G.; Cresta, S.; Yap, Y. S.; Juric, D.; Duhoux, F. P.; Terret, C.; Takahashi, S.; Layman, R. M.; Kundamal, N.; Baldoni, D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save